R
Richard F. Otten
Researcher at University of Michigan
Publications - 9
Citations - 266
Richard F. Otten is an academic researcher from University of Michigan. The author has contributed to research in topics: Acute coronary syndrome & Myocardial infarction. The author has an hindex of 6, co-authored 9 publications receiving 262 citations. Previous affiliations of Richard F. Otten include Indiana University – Purdue University Indianapolis.
Papers
More filters
Journal ArticleDOI
Adherence to Medications by Patients After Acute Coronary Syndromes
Anchal Sud,Eva Kline-Rogers,Kim A. Eagle,Jianming Fang,David F. Armstrong,Krishna Rangarajan,Richard F. Otten,Dana R Stafkey-Mailey,Stephanie D. Taylor,Steven R. Erickson +9 more
TL;DR: Determining beliefs about illness and medication may be helpful in developing interventions aimed at improving adherence after ACS, as not all patients continue their drugs or take them exactly as prescribed.
Journal ArticleDOI
Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome.
Rakesh Latchamsetty,Rakesh Latchamsetty,Jianming Fang,Eva Kline-Rogers,Debabrata Mukherjee,Richard F. Otten,Troy M. LaBounty,Michael S. Emery,Kim A. Eagle,James B. Froehlich +9 more
TL;DR: Independent of a history of renal insufficiency or increased admission creatinine, in-hospital worsening of renal function is an important risk factor for 6-month mortality in patients admitted with ACS and return to baseline function by discharge does not protect against this risk.
Journal ArticleDOI
Impact of pre-diabetic state on clinical outcomes in patients with acute coronary syndrome
Richard F. Otten,Eva Kline-Rogers,D J Meier,R Dumasia,Jianming Fang,N May,Y Resin,David F. Armstrong,Fadi Saab,Mircea Petrina,Kim A. Eagle,Debabrata Mukherjee +11 more
TL;DR: Admission plasma glucose was an independent predictor of non-fatal reinfarction, hospitalisation for heart failure, and a major adverse cardiovascular event (MACE) among non-diabetic patients with acute myocardial infarction.
Journal ArticleDOI
Comparison of outcomes in acute coronary syndrome in patients receiving statins within 24 hours of onset versus at later times
TL;DR: Patients who had acute coronary syndrome and received statins <24 hours of presentation had lower incidences of death, stroke, reinfarction, heart failure, and pulmonary edema compared with delayed administration.
Journal ArticleDOI
Impact of combination evidence based medical treatment in patients with acute coronary syndromes in various TIMI risk groups.
TL;DR: The treatment effect of combination therapy in patients stratified according to their risk of future cardiovascular events according to the thrombolysis in myocardial infarction (TIMI) risk score is assessed.